{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T12:20:22Z","timestamp":1763036422386,"version":"build-2065373602"},"reference-count":0,"publisher":"American Medical Association (AMA)","issue":"4","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2009,7,22]]},"DOI":"10.1001\/jama.2009.1019","type":"journal-article","created":{"date-parts":[[2009,7,21]],"date-time":"2009-07-21T20:17:52Z","timestamp":1248207472000},"page":"369","source":"Crossref","is-referenced-by-count":35,"title":["FDA Focuses on Drugs and Liver Damage"],"prefix":"10.1001","volume":"302","author":[{"given":"Bridget M.","family":"Kuehn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"10","container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jama.jamanetwork.com\/ama\/content_public\/journal\/jama\/4473\/jmn0722_369_371.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,8]],"date-time":"2023-04-08T01:00:21Z","timestamp":1680915621000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2009.1019"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2009,7,22]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2009,7,22]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2009.1019","relation":{},"ISSN":["0098-7484"],"issn-type":[{"type":"print","value":"0098-7484"}],"subject":[],"published":{"date-parts":[[2009,7,22]]}}}